Predicting Recurrence in Early Melanoma - Takeaway - MDSpire
From the Journals

Predicting Recurrence in Early Melanoma

Study identifies tumor features beyond staging that predict recurrence risk in early disease

Share

  • 1

    Study assessed recurrence in stages I and II melanoma.

  • 2

    Factors influencing recurrence included ulceration and tumor thickness.

  • 3

    16% of patients experienced recurrence over 7 years.

  • 4

    Distant recurrence was most common at 48%.

  • 5

    Significant recurrence rates correlated with tumor location on scalp and neck.

  • 6

    Additional pathologic variables can aid in surveillance recommendations.

  • 7

    Limitations included missing data and single-center design.

  • 8

    Study by Maya Mundada from UCSF.

Original Source(s)

Predicting Recurrence in Early Melanoma

  • by Andrea Surnit

  • April 1, 2026

Related Content

Forensic Dermatology and the CSI Effect

Media portrayals of forensic skin evidence create unrealistic jury expectations—and dermatologists testifying in court may need strategies to address them

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

UVB and Psoriasis: More Than Immunosuppression

UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.